Business Description
Epitomee Medical Ltd
ISIN : IL0011825911
Share Class Description:
EPTMF: Ordinary SharesDescription
Epitomee Medical Ltd is engaged in developing and commercializing ingestible therapeutic devices.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 8.79 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-Equity | 0.11 | |||||
Debt-to-EBITDA | -0.79 | |||||
Interest Coverage | 7.31 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 1.27 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -20 | |||||
3-Year Book Growth Rate | 105.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
9-Day RSI | 52.69 | |||||
14-Day RSI | 55.43 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 17.92 | |||||
Quick Ratio | 17.92 | |||||
Cash Ratio | 17.78 | |||||
Days Sales Outstanding | 14.44 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -7.03 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | 4.16 | |||||
Net Margin % | -56.82 | |||||
FCF Margin % | -119.96 | |||||
ROE % | -15.61 | |||||
ROA % | -11.71 | |||||
ROIC % | 4.52 | |||||
ROC (Joel Greenblatt) % | -73.06 | |||||
ROCE % | -12.07 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.34 | |||||
PB Ratio | 0.67 | |||||
Price-to-Tangible-Book | 0.67 | |||||
EV-to-EBIT | 1.26 | |||||
EV-to-EBITDA | 1.42 | |||||
EV-to-Revenue | -0.71 | |||||
EV-to-FCF | 0.59 | |||||
Price-to-Net-Current-Asset-Value | 0.79 | |||||
Price-to-Net-Cash | 0.79 | |||||
Earnings Yield (Greenblatt) % | 79.37 | |||||
FCF Yield % | -51.26 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:EPTMF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Epitomee Medical Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 10 | ||
EPS (TTM) ($) | 0 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 55.43 | ||
14-Day ATR ($) | 0.000066 | ||
20-Day SMA ($) | 0.9892 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 0.9488 - 1.0504 | ||
Shares Outstanding (Mil) | 29.76 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Epitomee Medical Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Epitomee Medical Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Epitomee Medical Ltd Frequently Asked Questions
What is Epitomee Medical Ltd(EPTMF)'s stock price today?
The current price of EPTMF is $0.99. The 52 week high of EPTMF is $1.05 and 52 week low is $0.95.
When is next earnings date of Epitomee Medical Ltd(EPTMF)?
The next earnings date of Epitomee Medical Ltd(EPTMF) is .
Does Epitomee Medical Ltd(EPTMF) pay dividends? If so, how much?
Epitomee Medical Ltd(EPTMF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |